| Net Income (Loss) Per Share |
11. Net Income (Loss) Per Share Basic and diluted net income (loss) per share for the three and six months ended June 30, 2026 and 2025 was calculated as follows (in thousands except share and per share amounts). | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Numerator: | | | | | | | | | | | | | Net income (loss) attributable to common stockholders for basic and diluted net income (loss) per share | | $ | 39,389 | | $ | (16,643) | | $ | (37,777) | | $ | (32,078) | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | | | Weighted average number of common shares outstanding - basic | | | 184,328,441 | | | 41,444,979 | | | 176,260,808 | | | 41,357,423 | Weighted average effect of potentially dilutive securities: | | | | | | | | | | | | | Effect of potentially dilutive common stock warrants | | | 31,524,859 | | | — | | | — | | | — | Effect of potentially dilutive restricted stock units | | | 1,489,713 | | | — | | | — | | | — | Weighted average common shares outstanding — diluted | | | 217,343,013 | | | 41,444,979 | | | 176,260,808 | | | 41,357,423 | | | | | | | | | | | | | | Net income (loss) per share attributable to common stockholders: | | | | | | | | | | | | | Basic | | $ | 0.21 | | $ | (0.40) | | $ | (0.21) | | $ | (0.78) | Diluted | | $ | 0.18 | | $ | (0.40) | | $ | (0.21) | | $ | (0.78) |
Included within weighted average common shares outstanding for the three and six months ended June 30, 2026 and 2025 are 80,773,954, and 5,450, respectively, common shares issuable upon the exercise of certain warrants, which are exercisable at any time for nominal consideration, and as such, the shares are considered outstanding for the purpose of calculating basic and diluted net loss per share attributable to common stockholders. The Company’s potentially dilutive securities include RSUs, stock options and warrants. The following table includes the potential shares of common stock, presented based on amounts outstanding at each period end, that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect: | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Options to purchase common stock | | 3,745,572 | | 5,031,973 | | 3,745,572 | | 5,031,973 | Warrants to purchase common stock | | 1,921,854 | | 3,285,316 | | 77,907,459 | | 3,285,316 | Restricted stock units to purchase common stock | | 14,139,884 | | — | | 16,581,971 | | — | | | 19,807,310 | | 8,317,289 | | 98,235,002 | | 8,317,289 |
|